H
H. Keipp Talbot
Researcher at Vanderbilt University Medical Center
Publications - 212
Citations - 12905
H. Keipp Talbot is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Vaccination & Medicine. The author has an hindex of 39, co-authored 152 publications receiving 6563 citations. Previous affiliations of H. Keipp Talbot include Vanderbilt University.
Papers
More filters
Journal ArticleDOI
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.
Shikha Garg,Shikha Garg,Lindsay Kim,Michael Whitaker,Alissa O’Halloran,Charisse N Cummings,Rachel Holstein,Mila M. Prill,Shua J Chai,Pam Daily Kirley,Nisha B Alden,Breanna Kawasaki,Kimberly Yousey-Hindes,Linda M. Niccolai,Evan J. Anderson,Evan J. Anderson,Kyle P Openo,Andrew Weigel,Maya Monroe,Patricia Ryan,Justin Henderson,Sue Kim,Kathy Como-Sabetti,Ruth Lynfield,Daniel M. Sosin,Salina Torres,Alison Muse,Nancy M. Bennett,Laurie M Billing,Melissa Sutton,Nicole West,William Schaffner,H. Keipp Talbot,Clarissa Aquino,Andrea George,Alicia P Budd,Lynnette Brammer,Gayle E Langley,Aron J. Hall,Alicia M. Fry +39 more
TL;DR: It is suggested that older adults have elevated rates of COVID-19-associated hospitalization and the majority of persons hospitalized with CO VID-19 have underlying medical conditions, which underscore the importance of preventive measures to protect older adults and persons with underlyingmedical conditions, as well as the general public.
Journal ArticleDOI
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
Abstr Act,Carlos A. DiazGranados,Andrew J. Dunning,Murray A Kimmel,John J. Treanor,Avi Collins,Richard Pollak,Janet Christoff,John Earl,Victoria Landolfi,Earl Martin,Sanjay Gurunathan,Richard P. Nathan,David P. Greenberg,Nadia Tornieporth,Michael D. Decker,H. Keipp Talbot +16 more
TL;DR: Among persons 65 years of age or older, IIV3-HD induced significantly higher antibody responses and provided better protection against laboratory-confirmed influenza illness than did IIV3-SD.
Journal ArticleDOI
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Adam S. Lauring,Mark W Tenforde,James D. Chappell,Manjusha Gaglani,Adit A. Ginde,Tresa McNeal,Shekhar Ghamande,David J. Douin,H. Keipp Talbot,Jonathan D Casey,Nicholas M. Mohr,Anne Zepeski,Nathan I. Shapiro,Kevin W Gibbs,D. Clark Files,David N. Hager,Arber N. Shehu,Matthew E. Prekker,Heidi L Erickson,Matthew C. Exline,Michelle N. Gong,Amira H. Mohamed,Nicholas J. Johnson,Vasisht Srinivasan,Jay S. Steingrub,Ithan D. Peltan,Samuel M. Brown,Emily T. Martin,Arnold S. Monto,Akram Khan,Catherine L. Hough,Laurence W. Busse,C. T. ten Lohuis,Abhijit Duggal,Jennifer G. Wilson,Alexandra June Gordon,Nida Abdul Qadir,Steven Y. Chang,Christopher Mallow,Carolina Gutiérrez Rivas,Hilary M. Babcock,Jennie H. Kwon,Natasha B. Halasa,Carlos G. Grijalva,Todd W. Rice,William B. Stubblefield,Adrienne Baughman,Kelsey N Womack,Jillian P. Rhoads,Christopher J. Lindsell,Kimberly W. Hart,Yuwei Zhu,K. Adams,Stephanie J. Schrag,Samantha M. Olson,M. Kobayashi,Jennifer R. Verani,Manish M. Patel,Wesley H. Self +58 more
TL;DR:
Journal ArticleDOI
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
Julia W. Gargano,Megan J. Wallace,Stephen C. Hadler,Gayle E Langley,John R. Su,Matthew E. Oster,Karen R. Broder,Julianne Gee,Eric Weintraub,Tom T. Shimabukuro,Heather M. Scobie,Danielle Moulia,Lauri E. Markowitz,Melinda Wharton,Veronica V. McNally,Jose R. Romero,H. Keipp Talbot,Grace M. Lee,Matthew F. Daley,Sara E. Oliver +19 more
TL;DR: In 2019, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine and the Moderna COVID19 (mRNA-1273) vaccine, and the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations for their use in persons aged ≥16 years and ≥18 years, respectively as mentioned in this paper.
Journal ArticleDOI
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
Mark W Tenforde,Wesley H. Self,Katherine Adams,Manjusha Gaglani,Adit A. Ginde,Tresa McNeal,Shekhar Ghamande,David J. Douin,H. Keipp Talbot,Jonathan D Casey,Nicholas M. Mohr,Anne Zepeski,Nathan I. Shapiro,Kevin W Gibbs,D. Clark Files,David N. Hager,Arber Shehu,Matthew E. Prekker,Heidi L Erickson,Matthew C. Exline,Michelle N. Gong,Amira Mohamed,Daniel J. Henning,Jay S. Steingrub,Ithan D. Peltan,Samuel M. Brown,Emily T. Martin,Arnold S. Monto,Akram Khan,Catherine L. Hough,Laurence W. Busse,Caitlin C Ten Lohuis,Abhijit Duggal,Jennifer G. Wilson,Alexandra June Gordon,Nida Qadir,Steven Y. Chang,Christopher Mallow,Carolina Rivas,Hilary M. Babcock,Jennie H. Kwon,Natasha B. Halasa,James D. Chappell,Adam S. Lauring,Carlos G. Grijalva,Todd W. Rice,Ian Jones,William B Stubblefield,Adrienne Baughman,Kelsey N Womack,Jillian P. Rhoads,Christopher J. Lindsell,Kimberly W. Hart,Yuwei Zhu,Samantha M. Olson,Miwako Kobayashi,Jennifer R. Verani,Manish M. Patel,Influenza +58 more
TL;DR: In this article, the authors evaluated the association between vaccination with mRNA COVID-19 vaccines and hospitalization, and the association with progression to critical disease, using multivariable logistic regression.